Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy

By afschroeder • June 21, 2025

Juarez Casillas JE, Nikitas J, Rettig MB, Reiter RE, Lee A, Steinberg ML, Valle L, Kalbasi TR, Calais J, Czernin J, Eala MA, Tsai S, Kane N, Solanki AA, Sexton R, Duriseti S, Berenji GR, Aronson WJ, Garraway IP, Chang MG, Kwon R, Lee SP, Nickols NG, Kishan AU. Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy. Eur Urol Oncol. 2025 Jun 19:S2588-9311(25)00169-5. doi: 10.1016/j.euo.2025.05.027. Epub ahead of print. PMID: 40541485.

Tags: Abiraterone acetate, Androgen annihilation therapy, Apalutamide, Cardiology/Epi, Castrate-sensitive prostate cancer, Hematology/Oncology, Leuprolide, Metastasis-directed therapy, Oligorecurrence, prostate cancer, Publications, Stereotactic body radiotherapy, Veterans Administration

Cardiovascular-specific PTH1R activation enhances exercise-induced cardiac remodeling in a mouse model of calcific atherosclerosis

Hon A, Lu M, Shao XM, Demer LL, Tintut Y. Cardiovascular-specific PTH1R activation enhances exercise-induced cardiac remodeling in a mouse model of calcific atherosclerosis. Biochem[...]

In-Hospital Initiation of SGLT2 Inhibitors in Patients with Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis

Ahmed M, Rana JS, Sajjad L, Zulfiqar E, Chandak V, Tul Ain Q, Ahmed R, Mentz RJ, Fonarow GC. In-Hospital Initiation of SGLT2 Inhibitors in[...]

The Research Post

Calais J, Czernin J. The Research Post. J Nucl Med. 2026 May 1;67(5):663. doi: 10.2967/jnumed.126.272505. PMID: 42067215.